BLOGS WEBSITE

MRFF: 2020 Respiratory Medicine Clinical Trials Research on COVID-19 grant opportunity

Applications to this Medical Research Future Fund (MRFF) Coronavirus Research Response: 2020 Respiratory Medicine Clinical Trials Research on COVID-19 grant opportunity must propose a clinical trial that accelerates the implementation of treatments for severe acute respiratory distress in patients infected with COVID-19 in order to support the response to the COVID-19 outbreak in Australia. Applicants should note that the research funded by this grant opportunity is not intended to be used for development of vaccines or anti-viral therapies for COVID-19. These issues are the subject of separate MRFF grant opportunities.

The objective of the 2020 Respiratory Medicine Clinical Trials Research on COVID-19 grant opportunity is to use clinical trials to accelerate the implementation of treatments for severe acute respiratory distress in patients infected with COVID 19. To be competitive for funding, applicants must propose a clinical trial that delivers against the above objective.

The intended outcome of the research funded under this priority is to use clinical trials to accelerate the implementation of safe and effective treatments for severe acute respiratory distress in patients infected with COVID 19. This includes the identification of plausible pathways to clinical practice within 12 months of commencement.

Note that limited time frames are available to complete streamlined applications to facilitate the commencement of research as soon as possible.

NHMRC is looking for research and industry experts to assess MRFF 2020 Respiratory Medicine Clinical Trials Research on COVID-19 grant opportunity applications – tell us about your expertise on NHMRC’s online portal.

Funding

A total of $5M is available.

Eligibility

Visit GrantConnect for eligibility details.

Submission requirements & due date

Further information

Need help?

This entry was posted in Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, Major National Competitive Grants (Cat 1). Bookmark the permalink.
 

Comments are closed.